CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Jun. 30, 2025	Mar. 31, 2025
Current assets:
Cash and cash equivalents	$ 97,373	$ 111,119
Short-term investments	305,967	372,685
Research and development incentives receivable	1,843	3,725
Prepaid expenses and other current assets	8,188	8,351
Total current assets	413,371	495,880
Property, plant and equipment, net	14,679	13,739
Research and development incentives receivable, non-current	431	0
Restricted cash	1,707	1,703
Other non-current assets	1,200	1,200
Right-of-use asset - operating leases	3,918	3,998
Right-of-use asset - financing leases	34,201	34,808
Total assets	469,507	551,328
Current liabilities:
Accounts payable	15,483	12,463
Accrued expenses and other current liabilities	40,041	45,916
Operating lease liabilities, current	1,220	1,184
Financing lease liabilities, current	2,820	2,799
Total current liabilities	59,564	62,362
Operating lease liabilities, non-current	2,953	3,076
Financing lease liabilities, non-current	22,542	22,729
Long term debt, net of discount	46,792	46,377
Other liabilities, non-current	941	941
Total liabilities	132,792	135,485
Commitments and contingencies (Note 14)
Stockholders' equity
Common stock, $0.001 par value; 150,000,000 shares authorized as of June 30, 2025 and March 31, 2025; 77,807,174 and 77,085,024 shares issued and outstanding as of June 30, 2025 and March 31, 2025, respectively	78	77
Additional paid-in capital	1,367,668	1,358,897
Accumulated deficit	(1,035,272)	(948,579)
Accumulated other comprehensive income	4,241	5,448
Total stockholders' equity	336,715	415,843
Total liabilities and stockholders' equity	$ 469,507	$ 551,328